$AKBA Therapeutics $1.25 is already programmed - Long/Call
Fully expect a good earnings report. Positive news from the company. Nothing but good news as far as this company is concerned. Earnings posting this week, and will not disappoint. We could see a nice jump up here.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。